Company Overview

Business Description

Sector
Health Care
Industry
Life Sciences Tools & Services
Headquarters
Korea KR
Employees
163
IPO date
Jul 22, 2015

Peptron Inc. is a South Korean biotech company that develops long-acting drug formulations, especially injectable medicines built from peptides and other difficult-to-deliver molecules. Its main job is to take active drug ingredients and turn them into products that stay in the body longer and can be dosed less often, which can make treatment easier for patients and doctors.

The company sells two main things: its own drug development programs and formulation know-how that can be used by pharmaceutical partners. In practice, it earns money through research and development collaborations, technology transfer, licensing, and product development work tied to specific drug candidates. Its customers are mostly drug makers and biotech companies that need help turning promising molecules into usable medicines.

What makes Peptron different is its role in the drug value chain. It is not a mass-market drug seller; it sits upstream, where chemistry and delivery design matter most. That gives it a niche business model built around technical expertise, partnerships, and specialized formulations rather than broad branded drug sales.

Peptron Inc Investor Relations

Address
37-24, Yuseong-daero 1628beon-gil, Yuseong-gu
Daejeon
Korea

Business Segments

Peptide drug development

Peptron develops peptide-based medicines and long-acting formulations for use in areas like endocrine and metabolic care.

Customers and revenue model

Drug delivery technology

Peptron builds formulation technology that helps medicines release over a longer period and be easier to use.

Customers and revenue model

Management

Mr. Ho-Il Choi

Chief Exec. Officer

Biography unavailable